Marker Therapeutics, Inc. · NASDAQ:MRKR
Blue Owl Capital Holdings LP reported a 5.18% stake in Marker Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 14, 2025
Blue Owl Capital Holdings LP reported a 5.18% stake in Marker Therapeutics, Inc., 554,250 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G).
- Stake
- 5.18%
- Shares
- 554,250
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Blue Owl Capital Holdings LP | 5.18% | 554,250 |
Source
Related
- Marker Therapeutics, Inc.
- Blue Owl Capital Holdings LP
- Marker Therapeutics, Inc. shareholders
- Schedule 13G/A · Blue Owl Capital Holdings LP · May 15, 2025
- Schedule 13D/A · New Enterprise Associates 16, L.P. · Nov 17, 2025
- Schedule 13G/A · Alyeska Investment Group, L.P. · Nov 14, 2025
- Schedule 13D/A · New Enterprise Associates 16, L.P. · Aug 18, 2025
- Schedule 13G · Alyeska Investment Group, L.P. · Feb 14, 2025
- Schedule 13D/A · New Enterprise Associates 16, L.P. · Dec 23, 2024